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Abstract
Background: In higher primates, although LH/CG play a critical role in the control of corpus luteum (CL) function,
the direct effects of progesterone (P4) in the maintenance of CL structure and function are unclear. Several
experiments were conducted in the bonnet monkey to examine direct effects of P4 on gene expression changes
in the CL, during induced luteolysis and the late luteal phase of natural cycles.
Methods: To identify differentially expressed genes encoding PR, PR binding factors, cofactors and PR downstream
signaling target genes, the genome-wide analysis data generated in CL of monkeys after LH/P4 depletion and LH
replacement were mined and validated by real-time RT-PCR analysis. Initially, expression of these P4 related genes
were determined in CL during different stages of luteal phase. The recently reported model system of induced
luteolysis, yet capable of responsive to tropic support, afforded an ideal situation to examine direct effects of P4 on
structure and function of CL. For this purpose, P4 was infused via ALZET pumps into monkeys 24 h after LH/P4
depletion to maintain mid luteal phase circulating P4 concentration (P4 replacement). In another experiment,
exogenous P4 was supplemented during late luteal phase to mimic early pregnancy.
Results: Based on the published microarray data, 45 genes were identified to be commonly regulated by LH and
P4. From these 19 genes belonging to PR signaling were selected to determine their expression in LH/P4 depletion
and P4 replacement experiments. These 19 genes when analyzed revealed 8 genes to be directly responsive to P4,
whereas the other genes to be regulated by both LH and P4. Progesterone supplementation for 24 h during the
late luteal phase also showed changes in expression of 17 out of 19 genes examined.
Conclusion: These results taken together suggest that P4 regulates, directly or indirectly, expression of a number
of genes involved in the CL structure and function.
Background
In mammals, the secretion of progesterone (P4)b yc o r -
pus luteum (CL) is absolutely essential for establishment
and, in some species, maintenance of pregnancy. In
higher primates, LH and chorionic gonadotropin (CG)
have been suggested to be the principal trophic factors
responsible for P4 secretion in the CL [1]. Whether P4
plays a role in the maintenance of structure and func-
tion of CL has not been fully elucidated in higher
primates. Rothchild postulated that P4 is the primary sti-
mulus of its own secretion and that intraluteal P4,
among other effects such as control of structural integ-
rity and steroidogenic capacity, is responsible for regula-
tion of production of luteolysin, the prostaglandin (PG)
F2a, within the CL [2,3]. More recent studies have pro-
vided several lines of evidence, some of them with
mechanistic insights, in support of the direct effects of
P4 on CL. Expression of progesterone receptor (PR) iso-
forms in CL have been reported in several mammalian
species [4-6]. Several studies have suggested that by way
of its proliferative and anti-apoptotic actions, P4
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[8-10], and cattle [11,12]. Like other steroid nuclear
receptors, PR utilizes a plethora of cofactors termed
coactivators or corepressors to regulate gene expression
[13]. The PR cofactors identified to date include coacti-
vators like (SRC1-3, CBP/p300 and NCOA1-3) [13] and
corepressors like NCOR1-2 involved in modulation of
PR activity in vivo [14,15].
We have recently standardized a GnRH R antagonist-
induced luteolysis model system in the monkey in
which induced luteolysis could be reversed by exogen-
ous LH administration [16]. Employing this model sys-
tem, microarray analysis of differentially expressed genes
in CL tissue during induced luteolysis and LH replace-
ment following induced luteolysis has been determined
[16]. The GnRH R antagonist-induced regressed CL
with ablated LH action, yet capable of responding to LH
replacement, affords an ideal situation to examine direct
effects of P4 on CL structure and function. Extensive tis-
sue remodeling with breakdown and renewal of extracel-
lular matrix (ECM) that occurs during spontaneous
luteolysis requires participation of matrix metalloprotei-
nases (MMPs) and their tissue inhibitors, TIMPs
[17-19]. It has been reported that decrease in P4 levels
during late luteal phase of the non fertile cycle is asso-
ciated with changes in expression of ECM regulators
[20]. It remains to be determined whether P4 regulates
expression of tissue proteinases, especially following
conception. The purpose of this study was to examine
effects of P4 action on gene expression changes and
function of CL. Experiments were carried out to deter-
mine expression of genes in CL tissue that encode dif-
ferent elements of PR complex and few downstream
targets of PR activation throughout the luteal phase,
after LH/P4 depletion, after P4 replacement and after P4
supplementation during the late luteal phase.
Methods
Reagents
Oligonucleotide primers were synthesized by Sigma-
Genosys, Bangalore, India. DyNAzyme™ II DNA poly-
merase (F-501L) was purchased from Finnzymes, Espoo,
F i n l a n d .M o l o n e ym u r i n el e u k e m i av i r u s( M M u L V )
reverse transcriptase (RT) and 100 bp DNA ladder were
obtained from MBI Fermentas GmbH (St. Leon-Rot,
Germany). Power SYBR
® Green PCR master mix was
obtained from Applied Biosystems, Foster City, CA,
USA. GnRH R antagonist [Cetrorelix
®;( C E T ) ]w a sa
kind gift from Asta Medica, Frankfurt, Germany.
ALZET
® Osmotic pump Model 2ML1 (infusion rate
10 μl/h) was obtained from Alza Corporation, Palo Alto,
CA. Antibodies specific to phospho-p38 (9211), phos-
pho-p42/44 MAPK (9101), p38 MAPK (9212), p42/44
MAPK (9102), pMKK3/6 (9231), p38 MAPK assay kit
(9820), MMP-9 (G657) and Phototype-HRP Western
detection system with horseradish peroxidase-linked
anti-rabbit IgG (7071) were purchased from Cell Signal-
ing Technology, Inc. Danvers, MA. Antibodies specific
to PR (sc-538), NCOA1 (sc-8995), NCOA2 (also desig-
nated as GRIP1; sc-8996), NCOA3 (sc-25742) were pro-
cured from Santa Cruz Biotechnology, Santa Cruz, CA.
Crystalline P4 (P0130) and all other reagents were pur-
chased from Sigma Aldrich Corp. St. Louis, MO or
sourced locally.
Animal protocols, blood samples and CL collection
Experimental protocols involving monkeys in this
study were approved by the Institutional Animal
Ethics Committee of the Indian Institute of Science,
Bangalore. Adult female bonnet monkeys (Macaca
radiata) weighing 3.3-5.1 kg were utilized for the
study. The general care and housing of monkeys have
been described elsewhere [21]. In this study, one day
after occurrence of peak E2 surge was designated as
day 1 of the luteal phase, and CL was collected on
designated days of the luteal phase and/or after
administration of different treatments (see below). To
retrieve CL from experimental monkeys, ovaries were
accessed by performing laparotomy under aseptic con-
ditions on ketamine hydrochloride (15 mg/kg BW)
and/or pentobarbital sodium (8-12 mg/kg BW)
anesthetized monkeys. Under sterile conditions, the
excised CL was transferred to a petri dish containing
filter paper, wiped dry, weighed, cut into 4-5 pieces,
placed in individual sterile cryovials, snap-frozen in
liquid nitrogen and stored at -70°C until analysis.
Experiment 1: Examination of differentially expressed
genes during induced luteolysis and LH replacement
experiments
In order to identify genes associated with LH and P4
receptor signaling, the microarray data of induced
luteolysis (LH/P4 depletion) and rescue of CL function
by exogenous LH replacement studies deposited
(#GSE7827 and #GSE8371) by us previously were
examined. The main focus was on identifying changes
in expression of genes associated with PR and genes
downstream of PR signaling. For this purpose, various
cofactors and corepressors (NCOA1-3, NCOR1-2,
FKBP4 and FKBP5) of PR were selected for analysis.
Expression of MMP-2 and 9, TIMP-3, ADAMTS-1,
PGRMC1, BMP5, CDH2, WNT7A, HOXA1, IHH
genes regarded as downstream target of gonadotropin
and/or PR signaling in CL and in traditional P4 target
tissues such as uterus were also examined [19,22-26].
The expanded forms of gene symbols used in this
study are provided in Table 1. Real time RT-PCR ana-
lysis was carried out on RNA samples isolated from
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mals) and LH/P4 d e p l e t i o n( n=5a n i m a l s ) ]a n dL H
rescue (LH replacement, n = 3 animals each for PBS
and LH treatments) of CL function experiments as
reported previously [16].
Experiment 2: Expression of various components of PR
signaling complex and PR target genes throughout the
luteal phase
To study expression of PR, various components of PR
signaling complex and some of the downstream target
genes of PR signaling, corpora lutea (n = 3 animals/
stage of luteal phase) were collected from monkeys at
early (day 5), mid (day 8), and late (day 14) stage of the
luteal phase of the menstrual cycle as reported pre-
viously [27]. Also, CL (n = 3 animals) was collected
from monkeys on day 1 of menstrual cycle (d1M), a
time point when luteolytic events are manifested. Blood
samples were collected from monkeys on the day of CL
collection for determination of P4 concentration.
Experiment 3: Effects of P4 replacement on expression of
PR, coactivators, corepressors and P4 target genes during
induced luteolysis
We have recently reported that replacement of LH post
LH/P4 depletion leads to brisk and sustained increase in
P4 concentration suggesting rescue of CL function
following reestablishment of LH levels [16]. In the pre-
sent experiments, we determined the direct effects of P4
on CL during absence of luteotrophic stimulus. The dif-
ferent components of the PR signaling complex and
expression of few genes considered as target of PR acti-
vation were examined. In experiment 3.1, with a view to
mimic mid luteal phase circulating P4 concentration,
exogenous P4 was administered through implantation of
P4 filled ALZET pumps to monkeys depleted of LH/P4
(P4 replacement model). For this purpose, pilot experi-
ments were carried out in adult female monkeys to
examine the feasibility of providing P4 as continuous
infusion by way of implantation of P4 filled ALZET
pump. Keeping in mind the limitation on use of organic
solvents compatible with the pump, initially 16 mg of P4
was dissolved in 300 μl of ethanol and the solution was
made up to 2 ml by propylene glycol and the entire
solution was transferred to 2 ML1 ALZET pump. It was
determined that three, 32.5 mg of P4 filled pumps that
provided infusion of 487.5 μg/30 μl/h, were required to
be implanted in anesthetized monkeys to establish circu-
lating P4 concentration higher or in the range of mid
luteal phase concentration. In order to determine the
time course of P4 secretion immediately before and at
different time intervals after injection of CET (LH/P4
depletion), monkeys on day 7 of the luteal phase (n = 3
animals) were administered CET (150 μg/kg BW, s.c.)
Table 1 List of expanded forms of gene symbols used
Sl. No. Gene symbol Gene name
1 PR Progesterone receptor
2 PGRMC1 Progesterone receptor membrane
component 1
3 FKBP4 FK506 binding protein 4
4 FKBP5 FK506 binding protein 5/peptidyl-prolyl
cis-trans isomerase FKBP5-like (M. mulatta)
5 NCOA1 Nuclear receptor coactivator 1
6 NCOA2 Nuclear receptor coactivator 2
7 NCOA3 Nuclear receptor coactivator 3
8 NCOR1 Nuclear receptor corepressor 1
9 NCOR2 Nuclear receptor corepressor 2
10 WNT7A Wingless-type MMTV integration
site family, member 7A
11 AREG Amphiregulin
12 BMP5 Bone morphogenetic protein 5
13 CDH2 Cadherin 2, type 1, N-cadherin
(neuronal)/cadherin-2-like (M. mulatta)
14 HOXA1 Homeobox A1
15 IHH Indian hedgehog
16 ADAMTS1 A disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 1/ADAM
metallopeptidase with thrombospondin type 1 motif, 1
17 MMP9 Matrix metallopeptidase 9
18 MMP2 Matrix metallopeptidase 2
19 TIMP3 Tissue inhibitor of metalloproteinase 3/TIMP metallopeptidase inhibitor 3 (M. mulatta)
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of menses. In experiment 3.2, three groups of monkeys
(n = 3-4 animals/group) were administered 5.25% glu-
cose (vehicle for CET treatment; VEH; group 1), CET
[150 μg/kg BW; (LH/P4 depletion); CET; group 2] and
CET (150 μg/kg BW) followed 24 h later with implanta-
tion of P4 filled three ALZET pumps designed to infuse
487.5 μgo fP 4/30 μl / hf o r2 4h[ C E T + P 4;( P 4 replace-
ment); group 3]. Blood samples were collected immedi-
ately before and at different time intervals throughout
the experiment. In group 3, ALZET pumps were
removed 24 h later, and further blood samples were col-
lected to monitor circulating P4 levels. Corpora lutea
were retrieved from monkeys of all three groups (VEH,
CET and CET+P4).
Experiment 4: Effects of P4 supplementation on CL
function during late luteal phase
An experiment was conducted to gain insight into direct
effects of increased P4 during rescue of CL function that
occurs during late luteal phase of the fertile menstrual
cycle. On day 13 of the luteal phase of non-mated
females, three P4 filled ALZET pumps (97.5 mg of P4)
were implanted for 24 h, CL (n = 3 animals) was har-
vested and the pumps were removed 24 h later. Blood
samples were collected immediately before and at differ-
ent time intervals during implantation and after retrieval
of CL as well as removal of implants for determining
the P4 secretion pattern. For purposes of comparison,
CL (n = 3 animals) was harvested from untreated mon-
keys (untreated control) on day 14 of the luteal phase of
the menstrual cycle.
RNA isolation
Total RNA was isolated from CL tissues obtained from
different experiments using TRI reagent according to
manufacturer’s instructions. RNA samples were analyzed
using NanoDrop ND-1000 UV-VIS spectrophotometer
and samples with A260/A280 values ~1.8 -1.9 were
selected for further analyses.
Real-time RT-PCR analysis
Real time RT-PCR analysis was carried out as described
previously [16]. Total RNA (1 μg) extracted from CL of
monkeys from various experiments were reverse tran-
scribed using MMuLV RT in Eppendorf mastercycler,
epgradient PCR machine. Briefly, In a 20 μl total reac-
tion, 1 μg of total RNA along with 1 μl of Oligo dT pri-
mer were incubated at 65°C for 10 min and then snap
chilled on ice for 5 min. To this RNA-Oligo dT hybrid,
a cocktail containing 4 μl of 5X RT buffer [250 mM
Tris HCl (pH 8.3 at 25°C), 250 mM KCl, 20 mM MgCl2
and 10 mM DTT], 10 mM dNTPs and DEPC treated
water were added followed by addition of 200 units
(1 μl) of Revert Aid™MMuLV RT enzyme. The reaction
mixture was incubated at 42°C for 60 min. The resulting
cDNAs were used as template for real time RT-PCR
analysis using gene specific primers. The primer pairs
were designed using Rhesus macaque sequences sub-
mitted at NCBI and ENSEMBL using Primer Express
software v2.0 (Applied Biosystems, Foster City, CA,
USA) spanning the exon-exon junction. The diluted
cDNA samples equivalent to 10 ng of total RNA were
subjected to analysis in Applied Biosystems 7500 Fast
Real Time PCR system with SDS v 1.4 program employ-
ing Power SYBR green 2X PCR master mix. The 10 μl
real time RT-PCR mixture contained cDNA equivalent
to 10 ng of total RNA, 5 μl of PCR master mix and
5 μM each of forward and reverse gene specific primers.
The initial denaturation was carried out at 95°C for
10 min, with further 40 cycles of denaturation (95°C for
30 sec), annealing (specific annealing temperature for
30 sec) and extension (72°C for 30 sec) with a final
extension of 5 min at 72°C. PCR reactions were carried
out in duplicates in 96 well plates. For each gene a no
template control (NTC) was included and dissociation/
melting curves were generated to determine the specifi-
city of primers. Real time RT-PCR data for each gene
was normalized using L19 expression level as internal
control within each cDNA sample. The fold change in
expression of the genes was determined using the ΔΔCt
method, which calculates the fold change using the for-
mula: Fold change = 2
-ΔΔCt,w h e r eC t= Threshold cycle
i.e. the cycle number at which the relative fluorescence
of test samples increases above the background fluores-
cence and ΔΔCt=[ C t gene of interest (treated sample)-
Ct of L19 (treated sample)] - [Ct gene of interest (con-
trol sample)-Ct of L19 (control sample)]. The list of
genes and details of the primers employed in the real
time RT-PCR analysis along with the annealing tem-
perature and expected product size are provided in
Table 2.
Hormone assays
E2 and P4 concentrations in serum were determined by
specific RIA as reported previously [21].
Immunoblotting analysis
Immunoblot analyses and in vitro P38MAPK (P38) assays
of CL tissue lysates were carried out as per published
procedures. Assays were carried out with equal amount
of protein lysates from the luteal tissue of various treat-
ments as reported previously from the laboratory [27].
Statistical analysis
Data were expressed as mean ± SEM. Statistical evaluation
of mean differences of serum P4 concentrations and real-
time RT-PCR expression among different experimental
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the Newman-Keuls multiple comparison tests (PRISM
GraphPad, version 4.0; GraphPad Software Inc., San
Diego, CA) and Student’s t- test to compare between two
groups. A P value of <0.05 was considered statistically sig-
nificant. The linear regression analysis on microarray and
real time RT-PCR data was done as reported earlier [16].
Results
Identification and validation of differentially expressed
genes in LH/P4 depletion and LH replacement
experiments
The experimental details of CL collection from LH/P4
depletion (CET-induced luteolysis) and LH replacement
(CET+LH) models and the microarray data comparing
Table 2 List of Primers used for real time RT-PCR analysis
S. No. Gene name Primer sequence (5’to 3’) Annealing temp (OC) Product size (bp)
1 PR F GCCACATTCAACACCCACTT 57.4 134
PR R CCTTCAGCTCAGTCATGACG
2 NCOA1 F CTGCACGTGGGGGATCAT 60.4 146
NCOA1 R CCTGGCTCATCTGGAGGGT
3 NCOA2 F CATGACCTCAGTGACCTCCGT 60.4 116
NCOA2 R CCATTCCAGGCAGCTGGTTT
4 NCOA3 F CACCACAGGGCAGATGAGTG 60.4 135
NCOA3 R TGTGGGGGGCTACTCATG
5 NCOR1 F GCATCGAGCTGCTGTTATCCC 62.9 145
NCOR1 R TCTCTGCCGCTGCTCCTCC
6 NCOR2 F AAGCAGCGAGCGGCTGCCAT 72.6 143
NCOR2 R TGCTGAGGGGCGTCGCTCTC
7 FKBP4 F GGGGACCGAGTCTTTGTCCACT 69.9 124
FKBP4 R CCCAAGCCTTGATGACCTCCC
8 MMP-2 F GCCACATTCTGGCCTGAGCT 62.4 151
MMP-2 R CCAGGCTGGTCAGTGGCTTG
9 MMP-9 F CTGGAGGTTCGACGTGAAG 55 155
MMP-9 R AACTCACGCGCCAGTAGAAG
10 TIMP3 F CAAGTACCAGTACCTGCTGACA 55.4 122
TIMP3 R GATAGTTCAGCCCCTTGC
11 BMP5 F CCTGAAGAGTCGGAGTACTCAG 59.2 139
BMP5 R GACTCTGGGTGGTCAGAGGA
12 CDH2 F CATCCCTCCAATCAACTTGCC 59.2 131
CDH2 R GAGGCTGGTCAGCTCCTG
13 HOXA1 F CTTCGCAGGACCAGGTCACTC 65.1 124
HOXA1 R GGTCCGAGGGGTAGGCTCG
14 IHH F GCCGCGCGGTGGACATCA 71.9 126
IHH R CGGAGCAATGCACGTGGGCC
15 FKBP5 F GGTGAAGCCCAGCTGCTC 66.7 114
FKBP5 R CTGGCACATGGAGATCTGC
16 PRMC1F CGCCGCTCAACCTGCTGCT 69.7 139
PRMC1 R GTGAAGTCGCGCCGCTTGAG
17 ADAMTS 1 F GCCGACTGGGAAAGCGGA 66.6 120
ADAMTS 1 R CCAGTTCCTGTGGGCTGTCC
18 WNT7A F AGCTGGGCTACGTGCTCAAGG 68.2 138
WNT7A R CCAGGTCCGTGTCCATGGG
19 AREG F GTTGCCCCAGAGACCGAGACG 72.6 113
AREG R CAGCATAATGGCCTGAGCCGA
20 L19 F GCCAACTCCCGTCAGCAGA 60 154
L19 R TGGCTGTACCCTTCCGCTT
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Ominibus (#GSE7827 and #GSE8371) have been
described previously [16]. The published microarray
data was mined for P4¬ responsive genes, and 45 differ-
entially expressed genes were identified based on criteria
of >1.5 fold change in both LH/P4 depletion and LH
replacement experiments. We narrowed down to the
45 genes by comparing our previous data on LH repla-
cement studies with P4- responsive genes reported in lit-
erature for other tissues [28,29]. From the 45 genes
identified, 19 genes belonging to steroidogenesis and P4
target/regulation related genes (PR, PR binding proteins,
cofactors, corepressors and some of the genes consid-
ered as downstream targets of PR activation) considered
necessary for CL structure and function were selected
for further studies. It should be noted that of the
19 genes, expression of only 12 genes was examined
during different stages of the luteal phase in experiment
2 and expression of all 19 genes was determined in
experiments 3 and 4.
Figure 1A shows microarray and real time RT-PCR
fold changes in expression of genes associated with PR
signaling/regulation in CL tissue from monkeys of LH/
P4¬ depletion and LH replacement models. Validation
of microarray data from LH/P4¬ depletion model by
real time RT-PCR analyses provided a good correlation
in expression changes of most genes examined except
for PR, NCOR1, and HOXA1 which showed higher
expression changes in real time RT-PCR analysis, while
expression of WNT7A and AREG genes showed inverse
correlation by real time RT-PCR analysis (Figure 1A).
The linear regression analysis on log2-transformed data
of microarray and real time RT-PCR analyses suggested
a good correlation (R = 0.5013, P = 0.0484). A number
of genes that were examined to be differentially
expressed after LH/P4¬ depletion were found to be
reversed following LH replacement (Figure 1B). Expres-
sion of P4¬ responsive genes like PR, NCOA3, TIMP3,
BMP5 and CDH2 was down regulated after LH replace-
ment, whereas expression of genes like NCOR1, NCOR2
and MMP-9 was up regulated after LH replacement
(Figure 1B). The microarray data and real time RT-PCR
data for LH replacement experiments showed good cor-
relation except for the observation of profound down
regulation in BMP5 expression by microarray analysis
than real time RT-PCR analysis (R = 0.7028, P =
0.0312).
Expression of PR cofactors and its downstream target
genes throughout the luteal phase
Real time RT-PCR analysis results of PR, NCOA1-3,
NCOR1-2, FKBP5, TIMP 3, MMP-2, ADAMTS-1, IHH
and HOXA1 in CL collected from different stages of
luteal phase are represented in Figure 2A. In order to
gain information on the fold expression changes during
different stages, expression of each gene at early (E)
stage was set as 1 and expression at other stages of
luteal phase was represented as fold change in relation
to the early stage. Corresponding to the waxing and
waning levels of circulating P4 throughout different
stages of the luteal phase, the expression of PR mRNA
was not statistically different (P > 0.05) across all the
stages of luteal phase (Figure 2A). The protein expres-
sion for PR isoform B was low at early stage and its
expression was high at all the other stages examined,
with higher expression at mid luteal phase compared to
early stage (1 vs 1.82 ± 0.2 fold; early vs mid stage,
respectively; P < 0.05) (Figure 2B). However, the protein
expression for PR isoform A was low at early and mid
stage, and became higher at later stages of the luteal
phase with late luteal stage being significantly higher (1
vs 1.45 ± 0.06 fold, early vs late stage, respectively; P <
0.05). The fold change in expression of NCOA1 mRNA
and protein was low at early and mid stage (Figure 2A),
and was significantly higher (P < 0.05) in CL collected
from monkeys on day 1 of menses (1 vs 3.62 ± 0.04
fold, early stage vs d1 M, respectively; P < 0.05). Expres-
sion of NCOA2 and NCOR2 mRNA was higher (P <
0.05) in the late stage CL compared to their expression
at early, mid and d1 M stages (Figure 2A), and the pro-
tein expression for NCOA2 was high in mid stage CL.
Expression changes of FKBP5 and NCOA3 mRNA did
not vary significantly during different stages of luteal
phase (P > 0.05; Figure 2A). The protein expression of
NCOA3 was high in mid stage CL compared to early
stage CL (1 vs 1.2 ± 0.05 fold, early vs mid stage,
respectively; P < 0.05, Figure 2B). The fold change in
expression of NCOR1 showed a progressive increase
with expression being higher in CL of late stage and d1
M compared to other stages (Figure 2A). The expression
of proteinase family genes such as TIMP3 and MMP-2
were higher in CL at late luteal stage compared to early
and mid luteal stages. Expression of ADAMTS-1, IHH
and HOXA1 in CL tissues collected at different
stages of luteal phase did not vary significantly (P >
0.05; Figure 2A).
Effects of P4 replacement on expression of PR,
coactivators and corepressors during induced luteolysis
Circulating P4 concentrations were 3.8 ± 0.3, 1.5 ± 0.07,
0.6 ± 0.1, 0.56 ± 0.01, 0.5 ± 0.04, 0.3 ± 0.05 and 0.6 ±
0.1 ng/ml, respectively at 0, 12, 24, 36, 48, 60 and 72 h
post LH/P4 depletion (CET treatment; Figure 3A). All
monkeys showed menses 96-120 h post LH/P4 deple-
tion. A brief outline of the experiment involving exogen-
ous P4 replacement is presented in Figure 3B. The P4
concentration in monkeys combined from all three
groups was 3.5 ± 0.6 ng/ml prior to VEH (n = 3) or
Suresh et al. Reproductive Biology and Endocrinology 2011, 9:20
http://www.rbej.com/content/9/1/20
Page 6 of 16CET (n = 7) treatment (Figure 3C), and were main-
tained higher (4.1 ± 0.3 and 4.98 ± 0.3 ng/ml) at 12 and
24 h after administration of VEH, whereas P4 concentra-
tions declined significantly 12 and 24 h post LH/P4
depletion (1.5 ± 0.07 and 0.6 ± 0.1 ng/ml at 12 and 24 h
respectively; P < 0.05, Figure 3C). Replacement of P4 by
w a yo fi m p l a n t a t i o no fP 4 containing ALZET pumps at
24 h post CET treatment resulted in significant (P <
0.05) increase in P4 concentrations within 6 h post treat-
m e n ta n dr e m a i n e dh i g ht h r o u g h o u tt h e2 4hd u r a t i o n
of implantation. Upon removal of P4 containing ALZET
pumps and lutectomy, P4 concentrations declined to
r e a c h1 . 3 8±0 . 6a n d0 . 7 6±0 . 1 7n g / m la t1 2a n d2 4h ,
respectively (Figure 3C).
To analyze gene expression changes post P4 replace-
ment, 19 genes were selected for real time RT-PCR ana-
lyses and the results were presented in Figure 4A. These
genes were selected for analysis based on literature data
from studies on classic P4 target organs, P4 responsive
cell lines as well as from our microarray data of the LH/
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Figure 1 Microarray and real time RT-PCR expression analyses of genes associated with PR signaling/regulation in CL tissue from
monkeys of LH/P4¬ depletion and LH replacement models. (A) Effects of LH/P4 depletion (CET treatment; n = 5 animals each for VEH and
CET treatments) and (B) LH replacement (CET+LH treatments; n = 3 animals each for CET+PBS and CET+LH treatments) on gene expression
changes in the CL tissue. Microarray data deposited at GEO with accession #s GSE7827 and GSE8371 were analyzed. Expression of P4 responsive
genes identified from the microarray data (i.e. having >1.5 fold cut off over VEH treatment) is expressed as fold expression change (mean ± SEM)
and further validated by real time RT-PCR analyses. The real time RT-PCR analysis was determined using ΔΔCt method (see materials and
methods). RT-PCR and microarray data are presented mean ± SEM of fold change above control.
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Page 7 of 16P4 depletion (CET induced luteolysis) experiments
[16,28,29]. Initially the fold change in expression of PR
mRNA was low in VEH treated monkeys, increased to
15 fold in LH/P4 depletion model, and then decreased
significantly (P < 0.05) after P4 replacement (Figure 4A)
s u g g e s t i n gP Rt ob eaP 4 target gene. Similar to pattern
of PR mRNA expression, the protein expression of PR
isoform B was low initially in CL of VEH treated mon-
keys and increased post LH/P4 d e p l e t i o n( 1v s2 . 7 2±
0.04 fold VEH vs CET, respectively; P < 0.05; Figure
4B), while reduced post P4 replacement. However, the
protein expression of PR isoform A was low in CL of
VEH treated monkeys and remained low thereafter in
both LH/P4 depletion and P4 replacement conditions
(Figure 4B). The fold change in expression of PGRMC1
and FKBP4 mRNA was significantly lower (P < 0.05)
after LH/P4 depletion and no significant effect was
observed after P4 replacement (Figure 4A). Expression
of NCOA1 mRNA decreased marginally after LH/P4
depletion while P4 replacement increased its expression
significantly by 3-4 fold (P < 0.05; Figure 4A) suggesting
NCOA1 mRNA to be regulated by P4 directly. However,
protein expression for NCOA1 increased significantly after
LH/P4 depletion (1 vs 2.38 ± 0.04 fold, VEH vs CET treat-
ment; P < 0.05) (Figure 4B), but no significant change was
observed following P4 replacement (P > 0.05). Messenger
levels of NCOA2 and FKBP5 in CL tissue did not signifi-
cantly change after LH/P4 depletion or P4 replacement
(P > 0.05; Figure 4A). On the other hand, the protein
expression for NCOA2 was significantly (P < 0.05) higher
after LH/P4 depletion (1 vs 1.87 ± 0.05 fold, VEH vs CET
treatment; P < 0.05). However, P4 replacement resulted in
significant decrease in protein levels (1 vs 0.38 ± 0.10 fold,
VEH vs CET+P4 treatment; P < 0.05) compared to CL
obtained from VEH or CET treated monkeys indicating
indirect/direct regulation of NCOA2 by P4 at the protein
level. Messenger levels of NCOA3 in CL tissue did not
change significantly after LH/P4 depletion or P4 replace-
ment (P > 0.05; Figure 4A). However, the protein expres-
sion for NCOA3 was low in CL from VEH treated
monkeys and increased significantly after LH/P4 depletion
(1 vs 3.10 ± 0.50 fold, VEH vs CET treatment; P < 0.05)
while decreased after P4 replacement (Figure 4B) suggest-
ing a role for P4 in the regulation of NCOA3 protein
Figure 2 Analysis of expression of genes encoding PR, its cofactors and P4 target genes in CL during different stages of the luteal
phase in monkeys. A) Real time RT-PCR fold change in expression (represented as mean ± SEM; n = 3 animals/stage of the luteal phase) of
various genes associated with PR signaling and its target genes. The fold expression change at early stage was set as 1 and fold changes in
other stages were expressed in relation to the early stage. Bars with different letters indicate significant (P < 0.05) change in the expression of
the individual gene examined. B) Immunoblot analysis of PR, NCOA1, NCOA2 and NCOA3 expression in CL collected during various stages of the
luteal phase. Immunoblots were analyzed by densitometry, and the densitometric value of early stage CL for each protein was set as 1 and
values at other stages of CL were expressed in relation to the early stage. For NCOA1 protein, the upper band indicated by asterisk was
considered for densitometric analysis. The statistical analysis details for densitometric values for each protein are provided in the results section.
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increased significantly 5-8 fold after LH/P4 depletion and
became lower following P4 replacement (P < 0.05; Figure
4A). Similarly expression of NCOR2 mRNA increased
(but not statistically significant) after LH/P4 depletion, but
had no effect following P4 replacement (Figure 4A).
Expression of WNT7A mRNA increased significantly (P <
0. 05; Figure 4A) after LH/P4 depletion, and the expression
decreased significantly (P < 0.05) after P4 replacement
demonstrating regulation of WNT7A mRNA by P4.
Expression of AREG mRNA decreased significantly (P <
0.05) after LH/P4 depletion and remained low post P4
replacement (Figure 4A). The fold change in expression of
BMP5 increased 3 fold after LH/P4 depletion, but the
expression decreased significantly (P < 0.05) upon P4
replacement (Figure 4A) suggesting BMP5 gene to be a P4
responsive gene. Though the fold change in expression of
cadherin (CDH2) tended to be higher (but not statistically
significant) after LH/P4 depletion showed no significant
change after P4 replacement (Figure 4A). Expression of
HOXA1 and IHH mRNA were increased significantly (P <
0.05) after LH/P4 depletion, while expression of HOXA1
mRNA decreased after P4 replacement, expression of IHH
mRNA did not change significantly after P4 replacement
(Figure 4A).
T h ef o l de x p r e s s i o nc h a n g eo fA D A M T S - 1m R N A
after LH/P4 depletion was lower compared to VEH
treatment (P < 0.05) and the expression increased signif-
icantly (P < 0.05) following P4 replacement (Figure 4A).
Fold change in expression of MMP-9 mRNA increased
post LH/P4 depletion, and decreased significantly post
P4 replacement (P < 0.05; Figure 4A) indicating indirect/
direct regulation of both ADAMTS-1 and MMP-9
mRNAs by P4 at the transcription level. Further, the
fold change in expression of other genes like MMP-2
and TIMP3 increased significantly following LH/P4
Figure 4 Analysis of expression of genes associated with PR, its cofactors and P4 target genes in CL of monkeys treated with VEH
(5.25% glucose injection at mid luteal phase), CET (LH/P4 depletion) and CET+P4 (P4 replacement). A) Real time RT-PCR expression
analysis of various genes associated with PR signaling and its target genes. The fold expression change for VEH group was set as 1 and values
for other groups were expressed in relation to the VEH group. For details on fold change calculation for real time RT-PCR analysis, see legend to
Figure 1. Bars with different letters are significantly (P < 0.05) different for the individual genes examined. B) Immunoblot analysis of PR, NCOA1,
NCOA2 and NCOA3 proteins in CL after LH/P4 depletion and P4 replacement. Immunoblots are analyzed by densitometry and densitometric
value for VEH group is set as 1 fold and values for other groups were expressed in relation to the VEH group. For NCOA1 protein, the upper
band indicated by asterisk was considered for densitometric analysis.
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Page 10 of 16depletion, but P4 replacement had no effect (P < 0.05;
Figure 4A).
Analysis of luteal tissue lysates for changes in P38 acti-
vation indicated that P38 activity was lower in CL after
LH/P4 depletion, however, P4 replacement increased P38
activation significantly (P < 0.05; Figure 5). In vitro
MAPK assays revealed lower levels of pATF-2, a sub-
strate for activated P38 kinase, in CL after LH/P4 deple-
t i o n ,w h e r e a s ,t h ee f f e c to fL H / P 4 depletion on pATF-2
levels was prevented by P4 replacement (Figure 5). The
kinetics of P38 activation was correlated with activation
of its upstream kinase, pMKK3/6 protein levels. LH/P4
depletion decreased the pMKK3/6 protein expression sig-
nificantly (P < 0.05), while P4 replacement increased its
levels significantly (P < 0.05; Figure 5) indicating other
components of MAP kinase signaling to be active post P4
replacement. Expression of other MAP kinase like ERK
was also determined. Phosphorylated ERK levels did not
change significantly in CL tissues both after LH/P4 deple-
tion and P4 replacement (P > 0.05; Figure 5).
Effects of P4 supplementation on gene expression
changes during the late luteal phase
Circulating P4 concentrations in monkeys before and after
implantation of P4 containing ALZET pumps and in
untreated control monkeys are shown in Figure 6A.
Implantation of P4 pumps resulted in significant (P < 0.05)
increase in concentrations of P4 i.e., 4.4 ± 0.64, 4.2 ± 0.37,
4.4 ± 0.35 ng/ml at 6, 12, 24 h post P4 supplementation,
respectively and the corresponding P4 concentrations from
untreated control monkeys were 0.70 ± 0.1, 0.6 ± 0.1 and
0.49 ± 0.03 ng/ml at 6, 12 and 24 h, respectively (Figure
6A). Real time RT-PCR analysis showed >2 fold up regula-
t i o no fP R ,N C O A 1 ,N C O A 3 ,N C O R 2 ,F K B P 4 ,F K B P 5 ,
CDH2, HOXA1 and AREG expression in P4 supplemented
monkeys, while expression of BMP5, MMP-2, PGRMC1,
and ADAMTS-1 was significantly down regulated (P <
0.05; Figure 6B). Immunoblot analysis for PR (both iso-
forms A&B) protein showed no significant change after P4
supplementation, whereas, immunoblot analysis for
NCOA1 and NCOA2 proteins showed significantly lower
(P < 0.05) expression after P4 supplementation (NCOA1, 1
vs 0.25 ± 0.2 fold, for NCOA2; 1 vs 0.62 ± 0.2 fold; Figure
6C). Immunoblot analysis for protein expression of
NCOA3 and MMP-9 showed lower levels after P4 supple-
mentation (not statistically significant P > 0.05; Figure 6C).
Discussion
Together with earlier reports for presence of PR in CL
of many other species, the results of expression of PR,
various binding proteins, cofactors and P4 regulation of
expression of few genes in the present study further
confirm P4 actions within the CL. The importance of P4
in the regulation of CL structure and function has been
demonstrated in rats. It was shown that P4 administra-
tion during postpartum period had an anti apoptotic
action in the CL [9]. Although the rat CL does not
express nuclear PR, it was suggested that P4 mediates its
action by binding to its membrane receptors [30]. In
recent years, the membrane receptor-mediated actions
of P4 appear to have emerged as an important mechan-
ism for activation of P4 signal transduction pathway. It
was reported that rat luteal cells express membrane and
progestin binding proteins, progestin membrane recep-
tor (PMR) a,P M Rb,P M Rg, membrane component 1
(PRMC1/PGMRC1) and Rda 288 [30]. In a recent study,
it was demonstrated that PGMRC1-dependent mechan-
ism appears to promote human granulose/luteal cell
survival [31] confirming the novel membrane-bound
progestin receptors with defined actions. In the present
study, expression of PGRMC1 was demonstrated in the
Figure 5 Changes in activation levels of MAPKs during LH/P4
depletion and P4 replacement treatments. Tissue lysates were
prepared from CL of monkeys receiving VEH, CET (LH/P4 depletion)
and CET+P4 (P4 replacement) treatments. The immunoblots shown
are from one of three independent experiments (CL from one
monkey at each time point was used per experiment). Immunoblots
for phospho MAPKs and total MAPKs were analyzed by
densitometry and the fold change in the protein levels of phospho/
total MAPKs compared between treatments are represented
numerically. b-actin was used as loading control.
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Page 11 of 16CL and its expression became lower after LH/P4 deple-
tion. This finding was similar to the earlier observation
reported previously in the rhesus macaque [6]. Further
r e s t o r a t i o no fP G R M C 1e x p ression was observed after
LH replacement in LH/P4 ablated rhesus macaque [6].
In contrast, in the present study PGRMC1 expression
was not restored following LH replacement in LH/P4
depleted monkeys. The difference in the findings
between the two studies could be attributed to differ-
ences in the treatment protocols employed and/or dif-
ferences in the response to LH replacement observed
between the two macaques.
Rothchild [2] aptly described CL as the most unique
e n d o c r i n eg l a n di nt h eb o d y ,s i n c et h e r ea p p e a r st ob e
large interspecies variations in the mechanisms of
regulation of its function. In higher primates, it is well
established that the sole trophic stimulus for P4 secretion
is the pulsatile secretion of pituitary LH. It is possible
that P4 may not have an important role in its own secre-
tion, but it might have an important role in maintaining
structural integrity of the CL capable of responding to
the luteotrophic stimulus. Hutchison and Zeleznik [32]
demonstrated the rescue of CL function in the hypothala-
mus lesioned monkeys after reestablishment of pulsatile
GnRH treatment indicating the resilience of CL tissue to
the deprivation of luteotrophic support for long periods.
In our studies, it was confirmed that CL was responsive
to luteotrophic support for up to 48 h following inhibi-
tion of pituitary LH secretion [16]. We utilized LH/P4
depleted and LH replacement model systems that did not
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Page 12 of 16require extreme surgical procedures, yet allow examining
the CL function during LH/P4 depletion period as well as
hormone replacement period. During induced luteolysis,
even though LH replacement had profound effects on
expression of several genes [16], but this could be the
result of both direct as well as indirect effects of LH. In
the present study, examination of direct effects of P4 on
CL tissue revealed changes in expression of PR and
NCOR1, but expression of many other genes involved in
PR activation were not significantly affected. Since, the
duration of P4 replacement lasted only for 24 h, for the
effect to be apparent a longer duration of P4 replacement
might be required. Alternatively, perhaps the effects of P4
on expression of genes may be observed only when high
intraluteal P4 levels as seen in functional CL is achieved.
In the present study, only circulating P4 levels were
mimicked but more studies are required to achieve the
high intra luteal P4 levels and determine its effect on the
luteal expression of genes.
Tissue proteinases and genes associated with tissue
remodelling namely, TIMPs, MMPs and ADAMTS-1 have
been examined in the CL tissues of higher primates. In the
present study, the findings of higher expression of TIMP3
and MMP-9 was observed during latter part of the luteal
phase which is in accordance with similar findings
reported for CL of the rhesus macaque [18]. It was pre-
viously reported that ADAMTS-1 expression was high in
early CL but declined thereafter at other stages of the
luteal phase in the rhesus macaque [22]. In the present
study, however, no discernible pattern of expression of
ADAMTS-1 was observed during the luteal phase. It
should be pointed out that in the rhesus macaque the
highest expression was seen only at day 2 of the luteal
phase, while in the present study the day 2 CL was not
examined. Treatment with GnRH R antagonists [i.e. LH/
P4 depletion models] in both the macaques resulted in
decreased expression of ADAMTS-1 at mid luteal phase.
Interestingly, LH replacement, but not steroid replace-
ment, prevented the decreased ADAMTS-1 expression
seen after GnRH R antagonist treatment in the rhesus
macaque, but in the present study both LH (observed only
in real time RT-PCR analysis) and P4 replacement treat-
ments restored or increased its expression. The reason for
different findings on ADAMTS-1 expression after P4 (in
the present study) or progestin (rhesus monkey; [22])
treatments is difficult to explain and perhaps, related to
treatment protocol employed in both these studies. Also,
the unexpected decrease in ADAMTS-1 expression seen
after P4 supplementation at late luteal phase observed in
the present study is difficult to explain. Additional experi-
ments are necessary to address the regulation of
ADAMTS-1 expression in the CL by LH and P4.
Stouffer and Young, 2004 [19] reported a differential
expression of MMP-9 with regulation of its expression
to be at different levels involving both transcriptional
and translational mechanisms in the CL of the rhesus
macaque. In the present study, expression of MMP-9 in
LH/P4 depletion and LH replacement studies remained
high, but P4 replacement decreased its expression, sug-
gesting MMP-9 expression appear to be regulated by P4.
In accordance with our data, regulation of MMP-9
expression by P4 had been reported by other investiga-
tions in studies involving human endometrial explants
and rabbit cervix [33,34]. It should be pointed out that
MMP-9 expression during spontaneous luteolysis [data
n o ts h o w n ]a n dP 4 supplementation during late luteal
phases did not show significant change indicating that
regulation of MMP-9 expression may be dependent on
circulating LH as well as P4 concentrations. The
decrease in expression of MMP-2 mRNA post P4 repla-
cement during late luteal phase was similar to the
reported decrease in MMP-2 expression in the human
CL after treatment with hCG to mimic early pregnancy
[ 2 0 ] .I ti sp o s s i b l et h a tL Ha n dP 4 may synergistically
act to regulate MMP-2 mRNA expression during the
late luteal phase following P4 replacement as both are
present in this model system, however, the molecular
mechanisms for this synergistic action needs to be clari-
fied. Decreased expression of pro-MMP-9, pro-MMP-2
and MMP-2 in endometrial cancer cell lines after in
vitro administration of medroxy progesterone acetate,
an synthetic progesterone preparation, [35] suggests that
ECM remodelling could well be controlled by P4 as well
as by LH in the CL tissue.
Expression of WNT7A, AREG, BMP5, HOXA1 and
IHH, which are regarded as P4 target genes in uterus
and mammary gland were examined in the CL after LH/
P4 depletion and P4 replacement. WNT7A coordinates a
variety of cell and developmental pathways and reported
to guide hormonal responses during postnatal uterine
growth [36]. In the present study, the observation that
P4 decreased WNT7A expression was similar to finding
reported in the uterus [25]. The observation of down
regulated expression of BMP5 upon P4 replacement in
the present study is consistent with the findings in
uterus. Both WNT7A and BMP5 pathways appear to be
interlinked since BMPs are shown to be induced by
WNT signaling in the neurons [37]. BMPs have been
shown to stimulate steroidogenesis and proliferation in
p o r c i n et h e c ac e l l s[ 3 8 ] ,b u tt h er o l eo fP 4 regulated
WNT and BMP genes on the structure and function of
CL remains to be determined. The observation of low
levels of phosphorylated P38 in CL post LH/P4 deple-
tion, and its reversal after P4 replacement are consistent
with similar findings reported in uterus and mammary
gland after P4 treatment in mice [39]. By activating the
MAP kinase pathway, P4 appears to activate a unique
biologically important molecule to control CL structure
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Page 13 of 16and function. It should be pointed out that changes in
dynamics of MAP kinase activities have been shown to
regulate CL function [27]. PR is known to be phos-
phorylated by various kinases including MAP kinases in
response to various physiological stimuli [40]. The acti-
vation of MAP kinases have been shown to regulate
expression and function of coactivators like NCOA1
[39] and NCOA3 [41]. Ligand-mediated down regulation
and extensive loss of nuclear steroid receptor protein is
well recognized and during this process, different phos-
phorylation pathways may affect the proteasome-
mediated degradation of nuclear receptors including PR
[40]. It is reported that NCOA3 is phosphorylated by
P38 and the phosphorylated NCOA3 is subjected to
degradation by proteasome [42]. Whether activation of
P38 by P4 would have a role in regulating similar pro-
cesses in the CL tissue remains to be addressed, how-
ever, the results in the present study suggest operation
of similar mechanism. Gene expression analysis of 19
genes belonging to PR signaling during LH/P4 depletion
and P4 replacement experiments revealed expression of
8 genes [(PR, NCOA1, NCOR1, WNT7A, BMP5,
HOXA1, ADAMTS-1 and MMP-9) and protein expres-
sion of 3 genes] to be directly regulated by P4.T h e
expression of other 11 genes appear to be regulated by
both LH and P4 i nt h eC L( s e eT a b l e3 ) .I no r d e rt o
further extend the observations of direct actions of P4
and to further delineate role of P4 in the regulation of
CL function, circulating P4 concentrations were
increased for 24 h to mimic early pregnancy levels dur-
ing the late luteal phase of the non fertile cycle. Expres-
sion of many of the genes examined was observed to be
differentially expressed indicating that P4 may have an
important role in the regulation of CL function during
e a r l yp r e g n a n c y .A l s o ,i ts h o u l db ep o i n t e do u tt h a tt h e
general housekeeping activity that include anti-apoptotic
actions, structural integrity of luteal cells and perhaps
regulation of expression of few genes associated with
overall maintenance of CL structure may be attributed
to direct or indirect actions of P4.
In summary, experiments were performed to examine
direct effects of P4¬ on the regulation of expression of
genes in the monkey CL. The first experiment com-
prised of analysis of previously published microarray
data to identify differentially expressed genes considered
as target of P4 action and validation of some of these
genes by real time RT-PCR analysis. In the second
experiment, expression of many of the genes identified
in the first experiment was examined throughout the
luteal phase. In the third experiment, the direct effects
Table 3 List of genes whose expression identified to be regulated by P4 treatment
Sl. No. Gene Changes in levels after Regulation by P4
LH/P4 depletion P4 replacement
1 PR mRNA up down Y
Protein (PR B) up down Y
Protein (PR A) - - N
2 NCOA1 mRNA - up N
Protein up - N
3 NCOA2 mRNA - - N
Protein up down Y
4 NCOA3 mRNA - - N
Protein up down Y
5 PGRMC1 down - N
6 FKBP4 down - N
7 FKBP5 - - N
8 NCOR1 up down Y
9 NCOR2 up - N
10 WNT7A up down Y
11 AREG down down N
12 BMP5 up down Y
13 CDH2 up - N
14 HOXA1 up down Y
15 IHH up - N
16 ADAMTS1 down up Y
17 MMP9 up down Y
18 MMP2 up - N
19 TIMP3 up - N
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Page 14 of 16of P4¬ on expression of many of these genes was exam-
ined following P4¬ replacement in monkeys depleted for
circulating endogenous LH and P4¬ by way of inhibition
of pituitary gonadotropin secretion. In the fourth experi-
ment, the effects of P4¬ supplementation on expression
of genes during the late luteal phase with declining endo-
genous P4¬ levels were examined. This experiment was
done to determine whether increased P4¬ seen during
early pregnancy regulate expression of these genes. The
results from these studies indicated that P4¬ appears to
regulate expression of many of the genes in the CL.
Conclusions
Experiments were carried out to assess the direct effects
of P4 on CL function in monkeys. Expression of some of
the genes involved in PR signaling and genes considered
as targets of LH and P4 was analyzed in LH/P4 depletion
and P4 replacement model as well as P4 supplementa-
tion model during the late luteal phase, and the results
i n d i c a t e dt h a te x p r e s s i o nof number of genes appeared
to be regulated directly or indirectly by P4. These results
suggest that replacement of P4 during LH/P4 depletion
(induced luteolysis model) is suitable for assessing the
effects of P4 on CL function. Further, these studies sug-
gest that CL could serve as a target tissue for examining
genomic and non genomic actions of P4.
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